Sclerostin expression and functions beyond the osteocyte

Megan Weivoda, Stephanie J. Youssef, Merry Jo Oursler

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Sclerostin, the product of the . SOST gene, is a secreted inhibitor of Wnt signaling that is produced by osteocytes to regulate bone formation. While it is often considered an osteocyte-specific protein, . SOST expression has been reported in numerous other cell types, including hypertrophic chondrocytes and cementocytes. Of interest, . SOST/sclerostin expression is altered in certain pathogenic conditions, including osteoarthritis and rheumatic joint disease, and it is unclear whether sclerostin plays a protective role or whether sclerostin may mediate disease pathogenesis. Therefore, as anti-sclerostin antibodies are being developed for the treatment of osteoporosis, it is important to understand the functions of sclerostin beyond the regulation of bone formation.

Original languageEnglish (US)
JournalBone
DOIs
StateAccepted/In press - Jun 14 2016

Fingerprint

Osteocytes
Osteogenesis
Joint Diseases
Chondrocytes
Rheumatic Diseases
Osteoarthritis
Osteoporosis
Anti-Idiotypic Antibodies
Genes
Proteins

Keywords

  • Ankylosing spondylitis
  • Osteoarthritis
  • Rheumatoid arthritis
  • Sclerostin
  • Wnt

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Histology
  • Physiology

Cite this

Sclerostin expression and functions beyond the osteocyte. / Weivoda, Megan; Youssef, Stephanie J.; Oursler, Merry Jo.

In: Bone, 14.06.2016.

Research output: Contribution to journalArticle

@article{e383adff927c4833959e6dcb93702e24,
title = "Sclerostin expression and functions beyond the osteocyte",
abstract = "Sclerostin, the product of the . SOST gene, is a secreted inhibitor of Wnt signaling that is produced by osteocytes to regulate bone formation. While it is often considered an osteocyte-specific protein, . SOST expression has been reported in numerous other cell types, including hypertrophic chondrocytes and cementocytes. Of interest, . SOST/sclerostin expression is altered in certain pathogenic conditions, including osteoarthritis and rheumatic joint disease, and it is unclear whether sclerostin plays a protective role or whether sclerostin may mediate disease pathogenesis. Therefore, as anti-sclerostin antibodies are being developed for the treatment of osteoporosis, it is important to understand the functions of sclerostin beyond the regulation of bone formation.",
keywords = "Ankylosing spondylitis, Osteoarthritis, Rheumatoid arthritis, Sclerostin, Wnt",
author = "Megan Weivoda and Youssef, {Stephanie J.} and Oursler, {Merry Jo}",
year = "2016",
month = "6",
day = "14",
doi = "10.1016/j.bone.2016.11.024",
language = "English (US)",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Sclerostin expression and functions beyond the osteocyte

AU - Weivoda, Megan

AU - Youssef, Stephanie J.

AU - Oursler, Merry Jo

PY - 2016/6/14

Y1 - 2016/6/14

N2 - Sclerostin, the product of the . SOST gene, is a secreted inhibitor of Wnt signaling that is produced by osteocytes to regulate bone formation. While it is often considered an osteocyte-specific protein, . SOST expression has been reported in numerous other cell types, including hypertrophic chondrocytes and cementocytes. Of interest, . SOST/sclerostin expression is altered in certain pathogenic conditions, including osteoarthritis and rheumatic joint disease, and it is unclear whether sclerostin plays a protective role or whether sclerostin may mediate disease pathogenesis. Therefore, as anti-sclerostin antibodies are being developed for the treatment of osteoporosis, it is important to understand the functions of sclerostin beyond the regulation of bone formation.

AB - Sclerostin, the product of the . SOST gene, is a secreted inhibitor of Wnt signaling that is produced by osteocytes to regulate bone formation. While it is often considered an osteocyte-specific protein, . SOST expression has been reported in numerous other cell types, including hypertrophic chondrocytes and cementocytes. Of interest, . SOST/sclerostin expression is altered in certain pathogenic conditions, including osteoarthritis and rheumatic joint disease, and it is unclear whether sclerostin plays a protective role or whether sclerostin may mediate disease pathogenesis. Therefore, as anti-sclerostin antibodies are being developed for the treatment of osteoporosis, it is important to understand the functions of sclerostin beyond the regulation of bone formation.

KW - Ankylosing spondylitis

KW - Osteoarthritis

KW - Rheumatoid arthritis

KW - Sclerostin

KW - Wnt

UR - http://www.scopus.com/inward/record.url?scp=85007339341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007339341&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2016.11.024

DO - 10.1016/j.bone.2016.11.024

M3 - Article

C2 - 27888056

AN - SCOPUS:85007339341

JO - Bone

JF - Bone

SN - 8756-3282

ER -